About this trial
The study hypothesis is that dilations of idiopathic bronchi are particularly common in French Polynesia, and that there are arguments in favour of an underlying genetic factor.
The study will retrieve retrospective data in the history of bronchial dilation, patients' personal and family history, microbiological and scannographic data, and the latest cardio respiratory checkup.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Polynesian patient
Patient with bronchial dilation followed by Centre hospitalier de Polynesie Francaise or patient with bonchial dilation no longer consulting in the hospital over the study period Jan 1, 2010 to Dec 31, 2020
Disqualifiers
Expressed refusal to participate in the study for patients undergoing follow-up
Trial population
500 patients with bronchial dilatation over the study period: Jan 1, 2010 to Dec 31, 2020
Trial design
Cohort
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Describe the detailed phenotype of bronchi dilation in the Polynesian population
* Clinical criteria: age of onset, personal or family history, smoking Changes in respiratory function * Infectious complications: types of bronchial colonization (bacterial, mycobacterial and mycological) * Scantographic aspect: Appearance of bronchectasis: cylindrical, varicose orcious, cystic Distributions: LSD, LM, LID, LSG, LIG
Secondary outcomes
Highlighting indirect arguments for a genetic cause
Age of onset of symptoms, frequency of so-called "idiopathic" bronchi dilatation, frequency of inbreeding, familial history
Sponsors and contacts
Click on the lead sponsor to view all of their trials.